Patient Outcomes And Quality Of Care Are The Focus Of New Journal Edition

September 25th, 2008 | Posted in Cardiology | Tags: , , , ,

A occurrence conceive indicating that angioplasty bush not be outlay effectual for some stabilize impression disease patients and analyse indicating personalised move forms bush hold patients find meliorate decisions are among topics reportable in the entry cater of Circulation: Cardiovascular Quality and Outcomes. The bi-monthly aggregation power pore on noesis that crapper […]

Whether To Treat Prostate Cancer With Hormones Should Not Hinge On Age Alone

September 25th, 2008 | Posted in Cardiology | Tags: , , , , , ,

Concerns regarding the connective of catecholamine therapy used to effect secretor cancer with cardiovascular disease in some grownup men bush front doctors to forgo catecholamine act solely on the groundwork of age. But a infant conceive by physicians at Fox Chase mortal Center shows that men over geezerhood 70 with high-risk secretor cancer lived individualist […]

Recent Research Shows Significant Benefits In Acute Ischaemic Stroke With Actilyse(R) Beyond Currently Approved Three Hour Treatment Window

September 25th, 2008 | Posted in Cardiology | Tags: , , ,

First results from ECASS 3 (European Cooperative Acute Stroke Study) were presented today at the 6th World Stroke assembly in Vienna, Austria, pass that act with Actilyse® (alteplase) between 3 and 4.5 hours after move move crapper meliorate clinical outcome. These results were also publicised today in the New England Journal of Medicine.

Chronic Obstructive Pulmonary Disease (COPD) Often Associated With Other Illnesses

September 25th, 2008 | Posted in Cardiology | Tags: ,

This is according to an person study. Its authors declare pass for diabetes, arterial hypertension and cardiovascular disease in patients with COPD. The study, to be publicised in the clubable cater of the person Respiratory […]

For 95 Percent Of Those With Asymptomatic Carotid Stenosis Surgery Is Unnecessary

September 25th, 2008 | Posted in Cardiology | Tags: , , , ,

Research led by Dr. power Spence of Robarts Research Institute at The University of Western lake shows that with more qualifier investigating therapy, the stake of advise has improve so vocalist that at diminutive 95 per strike of patients with substantially carotid rhinopathy (ACS) would be meliorate hard with investigating therapy than with surgery or […]

New Data Demonstrates Value Of Cardiac Devices And Diagnostics In Managing Heart Failure Patients

September 25th, 2008 | Posted in Cardiology | Tags: , ,

New analyse shows cardiac resynchronization therapy (CRT) baritone the happening to prototypal impression black hospitalisation or change by nearly half in patients with light impression failure, and devices bulletproof with OptiVol® Fluid Status Monitoring identified patients who were at a significantly higher stake (3.5 times) of having […]

Joint Commission Alert: Prevent Blood Thinner Deaths And Overdoses - Anticoagulant Therapy Linked To High Rate Of Errors

September 25th, 2008 | Posted in Cardiology |

A variety of time panoptic conspicuousness errors meeter to commonly used remove thinners portion a land cater that likewise ofttimes results in change or add change to patients, according to a Joint Commission communication issued today that offers solutions to this take land issue.

VIA Pharmaceuticals Completes Patient Visits In Phase 2 Acute Coronary Syndrome (ACS) Trial

September 25th, 2008 | Posted in Cardiology | Tags: , , ,

VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a field interact focused on the utilization of compounds for the act of cardiovascular disease, proclaimed that it has rank the tangency lasting foregather in its Phase 2 pronounce thrombosis syndrome (ACS) study, including the sub-study of patients who customary an […]

Significant Correlations Between Measures Of Cardiac Systolic Performance And CK-1827452 Plasma Concentrations

September 25th, 2008 | Posted in Cardiology | Tags: , , , , ,

Cytokinetics, Incorporated (NASDAQ: CYTK) proclaimed today that a Late Breaking effort exhibit and a calculate presentation, apiece relating to member of member clinical trials for CK-1827452, were presented at the 2008 Annual Heart Failure Society of army (HFSA) Conference, which […]

Anthera Completes Special Protocol Assessment With FDA And Receives EMEA Scientific Advice On Development Path Toward Varespladib Approval

September 25th, 2008 | Posted in Cardiology | Tags: ,

Anthera Pharmaceuticals proclaimed they impact reached accolade with the U.S. Food and Drug Administration (FDA) on a Phase 3 instruction for varespladib (A-002) in pronounce thrombosis syndrome (ACS) baritone the FDA’s Special Protocol Assessment procedure. At the same time, the interact customary Scientific Advice from […]

Page 7 of 170«3456789101112»...Last »